Acute Coronary Syndrome.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 24 hours after hospitalization Age 18_60 years Definitive diagnosis of acute coronary syndrome Patient consciousness Compelet health of the patient's visual and audiotory system No surgery Do not use norcotic drugs 5_6 hours before sleep Do not use psychiatric drugs Lack of known sleep disorder No history of neurological disorder Lack of background disease affecting sleep quality such as Rheumatoid Arthritis and migraine Patients with acute renal function, acute hepatic function, cognitive and neurological disorders and patients who are unable to communicate will not enter the study.
Exclusion criteria
Exclusion criteria: Acute problems during hospitalization or prescribing or taking natcotic drugs during the night.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nocturnal urinary melatonin levels. Timepoint: At the beginning of the study and three nights after using both earplugs and eye mask. Method of measurement: Concentration of 6 melatonin sulfatoxin as active metabolite by ELISA.;Nocturnal urinary cortisol levels. Timepoint: At the beginning of the study and three nights after using both earplugs and eye mask. Method of measurement: Active metabolites via radioimmunoassay. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of falling asleep. Timepoint: Before the intervention and at the end of three nights after the intervention. Method of measurement: Self-report questionnaire.;Frequent waking up during the night. Timepoint: Before the intervention and at the end of three nights after the intervention. Method of measurement: Self-report questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences